Upcoming Boston area forum on global access licensing!

Universities Allied for Essential Medicines (UAEM)
Forum on Global Access Licensing of Medical Technologies
Thursday, April 25th, 3-5pm
Coffee and refreshments at 2:45pm; reception following the event
Harvard Medical School New Research Building – 77 Avenue Louis Pasteur
Seminar Room 1031
Registration through this link is requested, but not required.

How do innovative medical technologies make their way to a global population, including patients in resource-limited settings? As centers of medical innovation, universities are well-placed to influence the global dissemination of the fruits of biomedical research and enhance access to advances in drug, vaccine, diagnostic and device technologies. In the past five years, several institutions in Boston and beyond have acknowledged this fact and taken bold steps to encourage the transfer of medical technologies to the developing world.In this Forum, technology transfer officials and academic research leaders from Harvard, MIT, Tufts, BU, Northeastern and Partners Healthcare (MGH/BWH) will speak to their institutions’ philosophy and experience with global access strategies. In an hour-long Q&A, the audience – including invited experts with significant experience in medical technology development – will contribute to the discussion. The Forum is open to the public, and researchers, entrepreneurs, university leaders and students are highly encouraged to attend.

Confirmed speakers at the event include:

  • Maryanne Fenerjian – Director of Technology Transfer Policy, Office of Technology   Development, Harvard University

  • Rebecca Menapace – Director, Research and Licensing, Research Ventures & Licensing, Partners Healthcare

  • Julie Myers – Commercialization Associate, Center for Research Innovation, Northeastern University

  • Lita Nelsen – Director, Technology Licensing Office, MIT

  • Vinit Nijhawan – Managing Director, Technology Development, Boston University

  • Andrei Ruckenstein – VP & Associate Provost for Research, Boston University

  • Martin Son – Associate Director, Technology Transfer, Tufts University

This event is co-sponsored by a grant from the Harvard Global Health Institute (HGHI), the HMS Division of Medical Sciences, and Harvard Law School Advocates for Human Rights.

Posted in Uncategorized | Comments Off

MIT Researchers create mutated antibodies to fight dengue

April 8th, 2013 MITnews

Nearly half of the world’s population is at risk of infection by the dengue virus, yet there is no specific treatment for the disease. Now a therapy to protect people from the virus could finally be a step closer, thanks to a team at MIT.

Posted in Uncategorized | Comments Off

Can a company patent a breast cancer gene?

December 10th, 2010 The Tech

Taking a new legal direction: genes are not patentable

The legality of patents on genes is in jeopardy after a judge ruled that genes were ineligible for patents because they involved “laws of nature.” Twenty percent of the human genome is currently patented.

Posted in Uncategorized | Comments Off

MIT scores poorly on the Global Health Report Card

April 8th, 2013 New York Times

Universities get middling grades in helping poor.

MIT ranks at #39 in terms of promoting research on neglected global diseases, ensuring that biomedical discoveries and innovations reach those in need, and preparing the next generation of global health leaders.

See the rankings and methodology at: http://globalhealthgrades.org/methodology/

Posted in Uncategorized | Comments Off

Low-Cost Drugs in Poor Nations Get a Lift in Indian Court

April 1st, 2013 New York Times

Allowing production of generic drugs is a very effective way to lower the cost and access barrier to medications. Recently, a ruling in Indian courts refused to restrict generic production of a patented leukemia drug that could cost $70,000 a year from Novartis or $2500 a year from a generic.

Posted in Uncategorized | Comments Off

Course for high school students on neglected diseases makes a Splash!

MIT student Maryam Zekavat (Course XX) teaches high school students about neglected tropical disease.


Posted on by essentialmeds | Comments Off